Stuart Lutzker
CIK: 0002009257
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AVBP
ArriVent BioPharma, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Lutzker Stuart
Lutzker Stuart (SEC CIK 0002009257) files insider reports with the SEC as President of R&D of ArriVent BioPharma, Inc. (AVBP).
Signal8 holds 2 ownership filings by Lutzker Stuart, all Form 4s, filed between Feb 14, 2025 and Feb 4, 2026. Those filings report 2 transactions, from Feb 3, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Lutzker Stuart's filings is in NEWTOWN SQUARE, PA.
Recent filings by Lutzker Stuart
Other insiders filing for ArriVent BioPharma, Inc. (AVBP)
- LaChapelle Robin, Chief Operating Officer
- Parsey Merdad, Director
- Peterson Kristine, Director
- Hohneker John, Director
- Nolet Chris, Director
- Kung Winston, Chief Financial Officer